Related Experiment Video
Updated: Mar 16, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Recent developments in the detection and management of acute kidney injury
James McCaffrey1, Ajaya Kumar Dhakal1,2, David V Milford3
1Department of Paediatric Nephrology, Central Manchester University Hospitals NHS Foundation Trust (CMFT), Manchester Academic Health Science Centre (MAHSC), Manchester, UK.
Insights
Acute kidney injury (AKI) in children is common, but current biomarkers are insensitive. New risk stratification and biomarker panels are needed for better detection and management of pediatric AKI.
Area of Science:
- Pediatric Nephrology
- Biomarker Discovery
- Critical Care Medicine
Background:
- Acute kidney injury (AKI) is a frequent complication in hospitalized children.
- Current serum and urine biomarkers for pediatric AKI lack sensitivity.
- There's a growing need for improved diagnostic tools in pediatric nephrology.
Purpose of the Study:
- To highlight advancements in risk stratification for pediatric AKI.
- To discuss the potential of novel AKI biomarkers in children.
- To emphasize the necessity of validation studies in diverse pediatric populations.
Main Methods:
- Review of recent developments in AKI risk stratification tools.
- Identification and discussion of emerging biomarkers for AKI detection.
- Analysis of current management principles for pediatric AKI.
Main Results:
- Risk stratification strategies are improving AKI prediction in children.
- New biomarkers show promise for earlier and more accurate AKI detection.
- Effective AKI management involves addressing underlying causes and appropriate fluid/medication use.
Conclusions:
- Combining risk stratification with a panel of AKI biomarkers can enhance early detection.
- Paediatric validation studies in mixed patient cohorts are crucial.
- Further research into the basic mechanisms of pediatric AKI is essential for therapeutic innovation.
Abstract:
Acute kidney injury (AKI) is a common condition in children admitted to hospital and existing serum and urine biomarkers are insensitive. There have been significant developments in stratifying the risk of AKI in children and also in the identification of new AKI biomarkers. Risk stratification coupled with a panel of AKI biomarkers will improve future detection of AKI, however, paediatric validation studies in mixed patient cohorts are required. The principles of effective management rely on treating the underlying cause and preventing secondary AKI by the appropriate use of fluids and medication. Further therapeutic innovation will depend on improving our understanding of the basic mechanisms underlying AKI in children.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations

